Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other 1

Conditions

Neoplasms 7Lung Neoplasms 6Colorectal Neoplasms 5Prostatic Neoplasms 3Smoking Cessation 2Neoplasm Metastasis 2Lymphoma 2Colonic Neoplasms 2Breast Neoplasms 2Uveal Melanoma 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Retroviridae Infections 1Pulmonary Disease, Chronic Obstructive 1Pancreatic cancer, adult 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasm, Residual 1Multiple Myeloma 1Motor Activity 1Leukemia 1Inflammation 1Glioblastoma 1Esophageal Neoplasms 1Dyspnea 1Disease 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Transitional Cell 1

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Hypnosis 1Hematologic Tests 1Educational Status 1Echocardiography 1Dexamethasone 1Calcium Dobesilate 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyspnea × Hematologic Tests × 1 year × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡